Shenzhen Neptunus Bioengineering Co

Shenzhen Neptunus Bioengineering Co Acquisitions (Net)

The Acquisitions (Net) of Shenzhen Neptunus Bioengineering Co (000078.SZ) as of Oct 17, 2026 is -55.63 M CNY. In the previous year, Acquisitions (Net) was -36.35 M CNY — a change of 53.03% (lower).

Acquisitions (Net)

-55.63 MCNY

YoY

53.03%

Last updated:

Acquisitions (Net) of Shenzhen Neptunus Bioengineering Co is 2024 -55.63 M CNY. Acquisitions (Net) of Shenzhen Neptunus Bioengineering Co was 2023 -36.35 M CNY. It decreases by 53.03% lower compared to the previous year.

The Shenzhen Neptunus Bioengineering Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
-1.16 B CNY
Jan 1, 2018
-1.53 B CNY
Jan 1, 2019
-159.50 M CNY
Jan 1, 2020
-83.90 M CNY
Jan 1, 2021
-479.97 M CNY
Jan 1, 2022
-180.78 M CNY
Jan 1, 2023
-36.35 M CNY
Jan 1, 2024
-55.63 M CNY
The Shenzhen Neptunus Bioengineering Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-55.63 MCNY+53.03%
-36.35 MCNY-79.89%
-180.78 MCNY-62.33%
-479.97 MCNY+472.07%
-83.90 MCNY-47.40%
-159.50 MCNY-89.60%
-1.53 BCNY+32.31%
-1.16 BCNY+158.00%
-449.30 MCNY-654.69%
81.00 MCNY-320.71%
-36.70 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shenzhen Neptunus Bioengineering Co Stock analysis

What does Shenzhen Neptunus Bioengineering Co do? Shenzhen Neptunus Bioengineering Co Ltd is a company based in Shenzhen, China, operating within the Health Care sector. The company has been publicly traded since its IPO on December 18, 1998, with a ticker symbol of 000078.SZ and ISIN CNE000000X95. It employs 9,874 people. The company's primary business involves the pharmaceutical industry, focusing on the development and distribution of various medical products. Its main product categories include anti-tumor medications, cardiovascular drugs, marine-derived pharmaceuticals, respiratory treatments, anti-infective products, and additional pharmaceuticals. The company also offers healthcare products, health food, and medical instruments. Shenzhen Neptunus Bioengineering Co Ltd primarily serves the domestic Chinese market, with a significant focus on the East China region. The company's official website is https://www.neptunusbio.com/. No additional details regarding founding year, specific acquisitions, or financial figures beyond the provided data are included in this profile. Shenzhen Neptunus Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shenzhen Neptunus Bioengineering Co stock

Acquisitions (Net) of Shenzhen Neptunus Bioengineering Co is -55.63 M CNY in 2024.

Acquisitions (Net) of Shenzhen Neptunus Bioengineering Co changed from -36.35 M CNY to -55.63 M CNY, representing a 53.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Shenzhen Neptunus Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Shenzhen Neptunus Bioengineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Shenzhen Neptunus Bioengineering Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Shenzhen Neptunus Bioengineering Co